Overview

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of tegaserod in opioid-induced constipation in patients with non-cancer pain.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Analgesics, Opioid
Tegaserod